Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liver Damage and Cardiometabolic Disorders in NAFLD
Sponsor: University of Roma La Sapienza
Summary
Liver fibrosis is the most important prognostic factor in patients with non-alcoholic factor disease. Clinical and biological condition, as diabetes or mutation for PNPLA3, are well known factors associated with liver fibrosis onset and progression. However, little is known about biochemical factors predicting liver fibrosis evolution in large NAFLD populations.
Official title: Progression of LIver Damage and Cardiometabolic Disorders in Non-alcoholic Fatty Liver dIsease: an Observational Cohort STUDY. The Plinio Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2011-11
Completion Date
2036-12-31
Last Updated
2019-08-16
Healthy Volunteers
No
Locations (1)
Day Service of Internal Medicine and Metabolic Disorders - Policlinico Umberto I - Sapienza University of Rome
Rome, Italy